All Content
All Content
Malcolm explains how trials become unblinded, either officially or through indicators in biomarkers.
The ADA just settled an explosive legal case accusing the organization of betraying people with diabetes.
Emily helps understand what hazard ratios are, what they can tell you about risks of a specific treatment, and how other factors like all-cause mortality also need to be considered when deciding on treatments.
By Emily KaplanEmily delves into the world of randomized clinical trials, explaining the steps in the process, the limitations of the trials, and common problems.
By Emily KaplanAnthony Garrett delivers a comprehensive lecture, touching on several major themes centered around the principles of probability, scientific methods, and the philosophical underpinnings of science.
A London librarian has analyzed millions of articles in search of uncommon terms abused by artificial intelligence programs.
Gerd dives into the history of statistical analysis in his field of psychology, which has led to a paradigm of rituals, in place of meaningful thought.
Frequently unreported or classified under a different cause, deaths from prescription drugs are on the rise. Peter Gøtzsche tallies up the totals and finds the risks to be higher than previously thought.